News Agency
Men's Weekly

Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca

  • Written by PR Newswire
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca

NATICK, Mass., Jan. 2, 2024 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, has entered into an exclusive option and global license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and...

Read more: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel...

How Family Lawyers Can Help Reduce Conflict During Separation

Separation is rarely straightforward, and the emotional weight it carries can make even practical decisions feel overwhelming. When communication between separating parties breaks down, disputes over property, finances and parenting arrangements can escalate quickly and become far more damaging than... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion